tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

REPL Stock Latest News

Replimune management to meet with Jefferies
The FlyReplimune management to meet with Jefferies
16d ago
REPL
Replimune price target raised to $19 from $16 at Jefferies
PremiumThe Fly
Replimune price target raised to $19 from $16 at Jefferies
1M ago
REPL
Replimune 6.923M share Spot Secondary priced at $13.00
PremiumThe Fly
Replimune 6.923M share Spot Secondary priced at $13.00
1M ago
REPL
Replimune announces proposed public offering of $125M of shares
PremiumThe Fly
Replimune announces proposed public offering of $125M of shares
1M ago
REPL
Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
PremiumThe Fly
Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
1M ago
BA
APG
Replimune price target raised to $18 from $14 at BMO Capital
PremiumThe FlyReplimune price target raised to $18 from $14 at BMO Capital
1M ago
REPL
Closing Bell Movers: Gap jumps 15% after Q3 earnings beat, guidance raise
Premium
The Fly
Closing Bell Movers: Gap jumps 15% after Q3 earnings beat, guidance raise
1M ago
BGC
GAP
Replimune Group Advances Cancer Treatment with FDA Submission
Premium
Company Announcements
Replimune Group Advances Cancer Treatment with FDA Submission
1M ago
8K
REPL
Replimune submits RP1 BLA to FDA, receives breakthrough therapy designation
PremiumThe Fly
Replimune submits RP1 BLA to FDA, receives breakthrough therapy designation
1M ago
REPL
Replimune Group’s Q3 2024 Financial Highlights
PremiumCompany Announcements
Replimune Group’s Q3 2024 Financial Highlights
2M ago
REPL
Replimune Group Navigates Clinical, Regulatory, and Market Challenges Amid Global Uncertainties
PremiumCompany Announcements
Replimune Group Navigates Clinical, Regulatory, and Market Challenges Amid Global Uncertainties
2M ago
REPL
Replimune reports Q2 EPS (68c), consensus (77c)
PremiumThe Fly
Replimune reports Q2 EPS (68c), consensus (77c)
2M ago
REPL
REPL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsREPL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
REPL
Replimune price target raised to $17 from $14 at JPMorgan
Premium
The Fly
Replimune price target raised to $17 from $14 at JPMorgan
3M ago
REPL
Replimune presents primary analysis data from IGNYTE clinical trial
Premium
The Fly
Replimune presents primary analysis data from IGNYTE clinical trial
4M ago
REPL
Replimune completes pre-BLA meeting with FDA for RP1
PremiumThe Fly
Replimune completes pre-BLA meeting with FDA for RP1
4M ago
REPL
Replimune appoints Balachandran to board of directors
PremiumThe Fly
Replimune appoints Balachandran to board of directors
4M ago
REPL
Replimune initiated with a Buy at Roth MKM
PremiumThe Fly
Replimune initiated with a Buy at Roth MKM
4M ago
REPL
Replimune announces first patient dosed in IGNYTE-3 trial
PremiumThe Fly
Replimune announces first patient dosed in IGNYTE-3 trial
5M ago
REPL
Replimune Group price target lowered to $14 from $17 at JPMorgan
PremiumThe FlyReplimune Group price target lowered to $14 from $17 at JPMorgan
5M ago
REPL
Replimune Group initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Replimune Group initiated with a Buy at Rodman & Renshaw
5M ago
REPL
Replimune Group files to sell 11.34M shares of common stock for holders
Premium
The Fly
Replimune Group files to sell 11.34M shares of common stock for holders
5M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >